Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . May 1st, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Fulminant Hepatitis - Murine viral fulminant hepatitis successfully treated by targeted delivery
Hepatitis B Virus - Hepatitis B virus seroconversion is associated with interleukin promoter polymorphisms
Hepatitis C Virus - Hepatitis C virus clearance and evolution mediated by HLA-B27 restricted CD8+ T cell response
Hepatitis C Virus - Hepatitis C virus E2 epitope characterized by neutralizing monoclonal antibody AP33
T Cells - T cell cross-reactivity influences hepatitis C virus-peptide specific response
Adverse Drug Reaction - Adverse drug reactions to antiretroviral drugs are influenced by hepatitis virus
Autoimmune Hepatitis - Autoimmune hepatitis in the elderly displays a distinctive clinical phenotype and treatment outcome
Diet & Nutrition - CCl4 -induced liver damage reduced with tropical almond leaf extracts
Drug Development - Gen-Probe submits amended regulatory application for PROCLEIX ULTRIO assay to U.S. FDA
Drug Resistance - Pegylated interferon is beneficial for lamivudine resistant chronic HBV infections
Genetics & Genomics - Mdr2 gene heterozygosity is linked to decreased PEMT activity and diminished steatohepatitis
HIV/AIDS - Reports from the United States and Japan add new data to HIV/AIDS research
Hepatic Fibrosis - Liver fibrosis serum panel markers evaluated in chronic hepatitis C
Hepatitis B Virus - Chronic hepatitis B deterioration of liver function traced using biomarkers
Hepatitis B Virus - Dendritic cells do not support the early steps of hepatitis B virus infection
Hepatitis B Virus - HBV antiviral effect is displayed by Phyllanthus nanus ethanolic extract
Hepatitis B Virus - HBV seropositivity is associated with allograft vasculopathy
Hepatitis B Virus - HBV tenofovir disoproxil fumarate therapy is effective in HIV-infected patients
Hepatitis B Virus - HBV X-related tumorigenicity is suppressed by an intracellular antibody
Hepatitis B Virus - New data from Japan and Taiwan lluminates research in hepatitis B virus
Hepatitis B Virus - New findings from the United States, People's Republic of China and Germany in the area of hepatitis B virus described
Hepatitis B Virus - Reports from Germany and the United Kingdom add new data to hepatitis B virus research
Hepatitis B Virus - Studies from South Africa, People's Republic of China and United States add new findings to hepatitis B virus body of knowledge
Hepatitis C Virus - Chronic HCV infection is associated with accumulation of dysfunctional effector CD8+ T cells
Hepatitis C Virus - Chronic hepatitis C cytolytic killing unaffected by decreased natural killer cell frequency
Hepatitis C Virus - Chronic hepatitis C virus benefits from consensus interferon and ribavirin
Hepatitis C Virus - Data from Brazil, Sweden and Italy advance knowledge in hepatitis C virus research
Hepatitis C Virus - Interferon-sensitive hepatitis C virus genotype 1 replication modeled
Hepatitis C Virus - New research from Switzerland and the United States in the area of hepatitis C virus detailed
Hepatitis C Virus - Non-responder hepatitis C patients benefit from amantadine triple therapy
Hepatitis C Virus - Researchers' data from Sweden, Japan and Israel advance hepatitis C virus research
Hepatitis C Virus - Researchers' work from the United States and Japan adds to hepatitis C virus body of knowledge
Hepatitis C Virus - Risk of severe hepatitis C recurrence after liver transplantation identified
Hepatocellular Cancer - HCC successfully embolized with yttrium-90 glass microspheres prior to liver transplantation
Hepatocellular Cancer - Hepatocellular carcinoma cell is enhanced by the hepatitis B x antigen effector
Hepatocellular Carcinoma - New findings from Taiwan and the People's Republic of China in the area of hepatocellular carcinoma detailed
Hepatocellular Carcinoma - Recent findings from the People's Republic of China, Japan and Taiwan illuminate research in hepatocellular carcinoma
Hepatocellular Carcinoma - Researchers from Singapore, Taiwan and the United States detail new studies and findings in the area of hepatocellular carcinoma
Liver Injury - Chronic hepatitis C associated liver injury is indicated by circulating level of tenascin-C
Liver Injury - Induced liver injury is prevented by lack of macrophage migration inhibitory factor
Nonalcoholic Fatty Liver Disease - Nonalcoholic fatty liver disease involves localized oxidized phosphatidylcholine
Transplants - Reports from Norway, Germany and Italy describe recent advances in transplants research
Transplants - Researchers' findings from the United States and Germany advance transplants research
Vaccine Development - Novel products to inject momentum into European vaccines market
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
